Information Provided By:
Fly News Breaks for August 25, 2016
MDT
Aug 25, 2016 | 09:10 EDT
Credit Suisse analyst Matthew Keeler raised long-term estimates for Medtronic and increased its price target to $92 to reflect the company's restated revenue reporting lines and raised its out-yer Diabetes and margin estimates. Keeler continues to see upside to shares given Medtronic's solid free cash flow, strong pipeline, and above-market topline growth. The analyst has an Outperform rating on Medtronic shares.
News For MDT From the Last 2 Days
There are no results for your query MDT
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.